NOVIGENIX
Novigenix is a Swiss precision medicine company specialized in ImmunoTranscriptomic solutions for the detection of disease, therapy optimization, and disease recurrence monitoring to improve disease management and patient outcomes. The Novigenix proprietary LITOseek platform is optimized for mapping the response of the immune system to onset and progression of disease by integrating patient multi-omics data, advanced Machine Learning, and artificial intelligence approaches, to provide actionab... le insights and precision solutions for optimization of patient’s therapeutic journey. Our product pipeline currently includes patient stratification solutions in the field of Immuno-Oncology, Colorectal Cancer early detection and recurrence monitoring, and therapy optimization solutions for management of cancer patients. Novigenix provides services to Pharma and Biotech customers by leveraging the proprietary LITOseek data analytics and patient clinical data platform to deliver previously unknown insights into the immune system, and develop ImmunoTranscriptomic solutions with actionable biomarkers for optimization of new therapeutic modalities.
NOVIGENIX
Social Links:
Industry:
Artificial Intelligence Biotechnology Health Diagnostics Life Science Machine Learning Predictive Analytics
Founded:
2014-01-01
Address:
Epalinges, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.novigenix.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
1000 K EUR
Technology used in webpage:
IPv6 Person Schema Gravatar Profiles Java EE QuoVadis
Current Employees Featured
Founder
Investors List
Eurostars
Eurostars investment in Grant - NOVIGENIX
Official Site Inspections
http://www.novigenix.com
- Host name: novigenix.com
- IP address: 93.88.247.115
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
More informations about "NOVIGENIX"
NOVIGENIX - Crunchbase Company Profile & Funding
Novigenix is a Swiss precision medicine company specialized in ImmunoTranscriptomic solutions for the detection of disease, therapy optimization, and disease recurrence monitoring to …See details»
Our Story - Novigenix
OUR STORY Novigenix helps bring intelligent insights into the heterogeneity of patient response to cancer and its treatment for development of better therapeutics. AI combined with access to …See details»
Novigenix SA - LinkedIn
Novigenix is a Swiss precision medicine company specialized in ImmunoTranscriptomic solutions for early detection of disease, development of novel therapeutics, and drug target discovery.See details»
Novigenix 2025 Company Profile: Valuation, Funding & Investors
Where is Novigenix headquartered? Novigenix is headquartered in Epalinges, Switzerland. What is the size of Novigenix? Novigenix has 26 total employees. What industry is Novigenix in? …See details»
Novigenix SA - Swiss Biotech
Novigenix is a Swiss precision medicine company specialized in ImmunoTranscriptomic solutions for the detection of disease, therapy optimization, and disease recurrence monitoring to …See details»
the leading Immuno-Transcriptomics company - Immuno …
The leading Immuno-Transcriptomics company: Generating insights from tumor-host interaction in order to detect cancer as early as possible and tailor the right treatment for the right patient.See details»
NOVIGENIX - Funding, Financials, Valuation & Investors
Novigenix is a precision medicine company that specializes in ImmunoTranscriptomic solutions. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. …See details»
Novigenix Company Profile - Office Locations, Competitors, …
Novigenix is a molecular diagnostics company specializing in liquid biopsy tests for early detection of cancer and precision medicine. Its technology is based on gene expression profiles of …See details»
Novigenix
Start-up du secteur biotech, nous sommes par essence un agent de changement et donc déterminé à faire bouger les lignes. Le cancer du côlon tue chaque année 1'600 personnes en …See details»
Novigenix • Biopôle • Switzerland
Novigenix is a Swiss precision medicine company specialized in ImmunoTranscriptomic solutions for the detection of disease, therapy optimization, and disease recurrence monitoring to …See details»
Novigenix - Team members, CEO, Employees - HealthTech Alpha
The Novigenix proprietary LITOseek platform is optimized for mapping the response of the immune system to onset and progression of disease by integrating patient multi-omics data, …See details»
Novigenix SA - VentureRadar
Novigenix is an innovative molecular diagnostics company specializing in new generation liquid biopsy tests for early detection of cancer and precision medicine. Novigenix is pioneering the …See details»
Novigenix Company Profile: Funding, Investors & Partnerships
Novigenix is a Swiss precision medicine company specialized in ImmunoTranscriptomic solutions for the detection of disease, therapy optimization, and disease recurrence monitoring to …See details»
Novigenix SA - startup.ch
Novigenix SA: Novigenix is a Swiss precision medicine company specialized in ImmunoTranscriptomic solutions for the detection of disease, therapy optimization, and …See details»
NOVIGENIX - Contacts, Employees, Board Members, Advisors
Novigenix is a precision medicine company that specializes in ImmunoTranscriptomic solutions. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. …See details»
Novigenix Company Information - Funding, Investors, and More
Novigenix is a Épalinges-based molecular diagnostics company developing blood tests for early detection of cancer founded in 2014. Seedtable Score 76 Startups. 1. Funding Rounds. …See details»
Novigenix announces first closing of its $20M Series B financing …
Expansion of Biopharma precision solutions in the field of Immuno-Oncology LAUSANNE, SWITZERLAND - November 15, 2022 – Novigenix SA, a leading data-driven precision …See details»
NOVIGENIX | EU-Startups
Nov 18, 2022 By combining patient multi-omics data, advanced Machine Learning, and artificial intelligence approaches, the Novigenix proprietary LITOseek platform is optimised for mapping …See details»
Soligenix Announces Publication Demonstrating CiVax™ Booster …
5 days ago COVID-19 has been declared a global pandemic by the World Health Organization. The global impact of this emerging infection demonstrates the urgent need for robust …See details»
Novigenix announces first closing of its $20M Series B - Novigenix
Expansion of Biopharma precision solutions in the field of Immuno-Oncology LAUSANNE, SWITZERLAND - November 15, 2022 – Novigenix SA, a leading data-driven precision …See details»